Pulmonary abscess due to leflunomide use in rheumatoid arthritis:: a case report

被引:8
|
作者
Ulusoy, H
Bilgici, A [1 ]
Kuru, O
Çelenk, Ç
机构
[1] Ondokuz Mayis Univ, Fac Med, Dept Phys Med & Rehabil, TR-55139 Samsun, Turkey
[2] Ondokuz Mayis Univ, Fac Med, Dept Radiol, Samsun, Turkey
关键词
infection; leflunomide; pulmonary abscess; rheumatoid arthritis;
D O I
10.1007/s00296-004-0493-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A 43-year-old woman had rheumatoid arthritis (RA) for 5 years and complained of fever, arthralgia/ myalgia, and night sweating for a month. She had been receiving only leflunomide (20 mg/day) for 5 months. On admission, there was no evidence of active arthritis or vasculitic lesion. Laboratory evaluation showed an erythrocyte sedimentation rate of 145 mm/h and C-reactive protein of 160 mg/dl. All cultures were negative. Chest radiograph and computed tomography (CT) revealed a pulmonary abscess. Staphylococcus aureus multiplied in the culture of a purulent sample obtained from the abscess under ultrasonography. The leflunomide was stopped, and sultamicillin (IV 4x2 g/day) was started for a further 6 weeks. Four weeks later, the patient had completely recovered and CT showed significant improvement of the pulmonary abscess. Ten milligrams/day of prednisolone and 7.5 mg/week of methotrexate were started for RA treatment. The patient has been under control for 5 months without any further abscess or RA activation.
引用
收藏
页码:139 / 142
页数:4
相关论文
共 50 条
  • [21] A Case of Interstitial Pneumonitis in a Patient with Rheumatoid Arthritis Treated with Leflunomide
    Shin, Ah-Young
    Kim, Seung Soo
    Kim, Kyung-Hee
    Ju, Il-Nam
    Ko, Hyeok Jae
    TUBERCULOSIS AND RESPIRATORY DISEASES, 2009, 66 (06) : 477 - 481
  • [22] Leflunomide-Induced Immune-Mediated Necrotizing Myopathy in a Patient With Rheumatoid Arthritis: A Case Report
    Salazar, Dylan Matthew
    Damani, Devanshi Narendra
    Kositangool, Piya
    Ortiz, Melina Jo
    Lavezo, Jonathan
    Dihowm, Fatma
    JOURNAL OF INVESTIGATIVE MEDICINE HIGH IMPACT CASE REPORTS, 2023, 11
  • [23] Leflunomide for the treatment of rheumatoid arthritis and autoimmunity
    Sanders, S
    Harisdangkul, V
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2002, 323 (04) : 190 - 193
  • [24] Safety evaluation of leflunomide in rheumatoid arthritis
    Keen, Helen I.
    Conaghan, Philip G.
    Tett, Susan E.
    EXPERT OPINION ON DRUG SAFETY, 2013, 12 (04) : 581 - 588
  • [25] Mechanism of action for leflunomide in rheumatoid arthritis
    Fox, RI
    Herrmann, ML
    Frangou, CG
    Wahl, GM
    Morris, RE
    Strand, V
    Kirschbaum, BJ
    CLINICAL IMMUNOLOGY, 1999, 93 (03) : 198 - 208
  • [26] Proposals for leflunomide use to avoid lung injury in patients with rheumatoid arthritis
    Inokuma, Shigeko
    Sato, Takeo
    Sagawa, Akira
    Matsuda, Takemasa
    Takemura, Tamiko
    Ohtsuka, Takeshi
    Saeki, Yukihiko
    Takeuchi, Tsutomu
    Sawada, Tetsuji
    MODERN RHEUMATOLOGY, 2008, 18 (05) : 442 - 446
  • [27] Benefit/risk of leflunomide in rheumatoid arthritis
    Kremer, JM
    Cannon, GW
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2004, 22 (05) : S95 - S100
  • [28] Clinical experience with leflunomide in rheumatoid arthritis
    Rozman, B
    JOURNAL OF RHEUMATOLOGY, 1998, 25 : 27 - 32
  • [29] Mechanism of action of leflunomide in rheumatoid arthritis
    Fox, RI
    JOURNAL OF RHEUMATOLOGY, 1998, 25 : 20 - 26
  • [30] Diffuse alveolar damage in a patient with rheumatoid arthritis under prolonged leflunomide treatment: A Case Report and Literature Review
    Keng, Li-Ta
    Lin, Mong-Wei
    Huang, Hsien-Neng
    Chung, Kuei-Pin
    MEDICINE, 2016, 95 (26)